These results indicate that tumor-cell-derived sEVs promote the release of bioactive factors (VEGF, lipids, and lactate) and the formation of a hypoxic microenvironment that accelerates the cellular metabolism around tumor tissue and the development and metastasis of CRC (Figure 3). The gene discussed is VEGFA; the disease is neoplasm.